Leadership Overview
Bharat Serums And Vaccines has 10 executives leading key functions including international operations, domestic business, medical strategy, quality assurance, and supply chain management.
Focused on advancing biopharmaceutical innovation, Bharat Serums And Vaccines delivers critical therapeutic solutions across women's health and assisted reproductive technology to improve global patient outcomes.
Focused on advancing biopharmaceutical innovation, Bharat Serums And Vaccines delivers critical therapeutic solutions across women's health and assisted reproductive technology to improve global patient outcomes.
Leadership Roles at Bharat Serums And Vaccines
Rahul Adakmol - Global Chief Operating Officer, International Operations & Business Development
Rahul Adakmol, the Global Chief Operating Officer, International Operations & Business Development at Bharat Serums And Vaccines, directs the expansion of biopharmaceutical market reach across diverse international territories. Adakmol architects strategic partnerships to scale the distribution of critical care and reproductive health products. By aligning international business development with corporate growth objectives, the Global Chief Operating Officer, International Operations & Business Development ensures consistent revenue streams in emerging markets. Rahul Adakmol monitors regulatory landscapes to facilitate seamless product entry into new regions. This leadership role involves optimizing cross-border logistics and fostering relationships with global healthcare stakeholders. Through rigorous market analysis, Adakmol drives the adoption of innovative biological treatments. The Global Chief Operating Officer, International Operations & Business Development maintains a focus on operational excellence, ensuring that international business units meet stringent quality standards while supporting the broader mission of saving lives through advanced pharmaceutical solutions.
Sivani Deka - Chief Operating Officer, Business (India)
Sivani Deka, the Chief Operating Officer, Business (India) at Bharat Serums And Vaccines, manages the domestic commercial strategy for a wide range of pharmaceutical and biotech products. Deka oversees the execution of sales initiatives within the Indian market, ensuring that women's health and critical care portfolios reach healthcare providers efficiently. The Chief Operating Officer, Business (India) coordinates with internal teams to enhance product accessibility and market penetration. Sivani Deka drives operational efficiency across regional sales networks to support the company's growth trajectory. This role involves analyzing domestic market trends to refine product positioning and maximize health outcomes for patients. By fostering collaboration between marketing and distribution departments, the Chief Operating Officer, Business (India) ensures alignment with the overarching corporate mission. Deka maintains a focus on sustainable growth, leveraging deep industry knowledge to navigate the complexities of the Indian pharmaceutical landscape while delivering high-quality therapeutic solutions to the healthcare sector.
Shailesh Pednekar - Chief Operating Officer, International Business
Shailesh Pednekar, the Chief Operating Officer, International Business at Bharat Serums And Vaccines, leads the strategic deployment of pharmaceutical assets across global markets. Pednekar directs the operational framework for international business units, focusing on the delivery of specialized biological products. The Chief Operating Officer, International Business architects robust supply chain solutions to ensure product availability in international healthcare systems. Shailesh Pednekar monitors competitive dynamics to maintain a strong market position for the company's critical care offerings. This leadership role involves managing complex international regulatory requirements and ensuring compliance with global health standards. By optimizing operational workflows, the Chief Operating Officer, International Business supports the expansion of the company's footprint in key geographic regions. Pednekar drives initiatives that enhance the efficacy of international sales operations, ensuring that the organization meets its long-term objectives for global health impact and sustainable commercial success.
Sanjeeb Mishra - President, Quality
Sanjeeb Mishra, the President, Quality at Bharat Serums And Vaccines, establishes the quality management systems that govern all manufacturing and research processes. Mishra directs the implementation of global quality standards to ensure the safety and reliability of every pharmaceutical product. The President, Quality oversees the compliance framework, ensuring that all operations adhere to international regulatory requirements. Sanjeeb Mishra monitors quality metrics across all production facilities to maintain the highest levels of excellence. This leadership role involves fostering a culture of continuous improvement and rigorous testing protocols. By managing quality assurance teams, the President, Quality ensures that the company's commitment to patient safety remains at the forefront of all operations. Mishra drives the adoption of advanced quality control technologies, supporting the company's mission to deliver high-quality, life-saving treatments to patients globally while maintaining strict adherence to industry-leading quality benchmarks.
Lakhiram Petwal - President, Operations
Lakhiram Petwal, the President, Operations at Bharat Serums And Vaccines, manages the end-to-end manufacturing and production capabilities of the organization. Petwal directs the operational activities across all facilities, ensuring that the production of biological and pharmaceutical products meets market demand. The President, Operations architects scalable manufacturing processes to support the company's growth in critical therapeutic areas. Lakhiram Petwal oversees the allocation of resources and the optimization of production workflows to enhance operational efficiency. This leadership role involves coordinating with supply chain and quality teams to ensure seamless product delivery. By driving operational excellence, the President, Operations supports the company's mission to provide accessible and innovative treatments. Petwal maintains a focus on safety and productivity, ensuring that all manufacturing operations align with the company's long-term strategic goals and commitment to improving patient health outcomes through reliable, high-quality production.
Anil Damle - Senior President, Corporate Projects & Supply Chain
Anil Damle, the Senior President, Corporate Projects & Supply Chain at Bharat Serums And Vaccines, manages the strategic infrastructure and logistics network required to support global operations. Damle directs the execution of large-scale corporate projects that enhance manufacturing capacity and operational reach. The Senior President, Corporate Projects & Supply Chain architects efficient supply chain solutions to ensure the timely delivery of pharmaceutical products. Anil Damle monitors global logistics trends to mitigate risks and optimize distribution channels. This leadership role involves coordinating with cross-functional teams to align project timelines with business objectives. By streamlining supply chain processes, the Senior President, Corporate Projects & Supply Chain supports the company's ability to meet patient needs effectively. Damle drives initiatives that improve operational agility, ensuring that the organization maintains a robust and responsive supply chain capable of supporting the company's mission of delivering life-saving treatments.
Anish Shah - President
Anish Shah, the President at Bharat Serums And Vaccines, provides executive leadership across the organization's diverse business units. Shah directs the strategic vision, ensuring that the company's biopharmaceutical focus remains aligned with market needs and patient requirements. The President oversees the integration of research, manufacturing, and commercial operations to drive sustainable growth. Anish Shah fosters collaboration among the leadership team to advance the company's mission of improving health outcomes. This leadership role involves setting long-term objectives and monitoring the performance of key business functions. By championing innovation and operational excellence, the President supports the company's position as a leader in the pharmaceutical industry. Shah drives initiatives that expand the company's reach, ensuring that the organization continues to deliver high-quality, life-saving treatments while maintaining a strong commitment to scientific advancement and patient-centric care.
Jaby Jacob - Senior President
Jaby Jacob, the Senior President at Bharat Serums And Vaccines, leads strategic initiatives that strengthen the company's market presence and operational capabilities. Jacob directs the development of high-level business strategies that support the company's growth in critical therapeutic areas. The Senior President oversees the alignment of organizational goals with the company's mission to provide innovative pharmaceutical solutions. Jaby Jacob collaborates with other executive leaders to optimize business performance and drive efficiency across departments. This leadership role involves identifying new opportunities for expansion and ensuring that the company remains competitive in the global biopharmaceutical landscape. By fostering a culture of excellence, the Senior President supports the company's commitment to delivering positive health outcomes. Jacob drives the execution of key corporate priorities, ensuring that the organization maintains its focus on scientific innovation and patient care while achieving sustainable commercial success.
Rudradev Mukherjee - President, International Business
Rudradev Mukherjee, the President, International Business at Bharat Serums And Vaccines, manages the global commercial strategy for the company's pharmaceutical portfolio. Mukherjee directs the expansion of international market operations, focusing on increasing the accessibility of critical care and reproductive health products. The President, International Business architects market entry strategies to navigate diverse regulatory and healthcare environments. Rudradev Mukherjee monitors international performance metrics to ensure that global business units meet growth targets. This leadership role involves building strategic alliances with international partners to enhance the company's global footprint. By driving the adoption of innovative treatments in international markets, the President, International Business supports the company's mission to improve patient lives globally. Mukherjee maintains a focus on operational efficiency and market responsiveness, ensuring that the organization delivers high-quality therapeutic solutions to patients across various international regions while achieving long-term commercial objectives.
Swashraya Shah - Chief Medical Officer
Swashraya Shah, the Chief Medical Officer at Bharat Serums And Vaccines, oversees the clinical strategy and medical governance for the entire product portfolio. Shah directs the research and development efforts, ensuring that all pharmaceutical and biotech innovations meet rigorous safety and efficacy standards. The Chief Medical Officer provides clinical oversight for the development of treatments in women's health and assisted reproductive technology. Swashraya Shah collaborates with the team of scientists to advance the company's pipeline of biological products. This leadership role involves engaging with medical communities to communicate the clinical value of therapeutic solutions. By maintaining high standards of medical integrity, the Chief Medical Officer ensures that all products contribute positively to patient health outcomes. Shah drives the integration of clinical data into business strategy, supporting the company's commitment to saving lives through science-led innovation and evidence-based medical practices.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership MS

GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership SN

SV
Proxima Research International LLC is a company that operates in the Pharmaceuticals industry. It employs 500to999 people and has 25Mto50M of revenue. The company is headquartered in Fort Lauderdale, Florida.
Company Leadership OK
EK
AA
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership YB
YS
AH